mRNA vaccines in cancer immunotherapy: clinical benefits, limitations, and future

Sijia Yang

doi:10.1117/12.2669938

24 March 2023 mRNA vaccines in cancer immunotherapy: clinical benefits, limitations, and future

Sijia Yang

Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 126116A (2023) https://doi.org/10.1117/12.2669938
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom

Abstract

The emergence of immunotherapy has created new opportunities for the treatment of cancer, which has been one of the main causes of death in the world. mRNA therapeutic vaccines are increasingly the focus of current research as a form of immunotherapy due to their rapid and scalable manufacture. mRNA can encode multiple antigens simultaneously, including those specific to personalized vaccines. This paper analyses mRNA vaccines in combination with other therapies describes their side effects summarises their limitations and potential problems, and discusses the current status of mRNA vaccines, providing directions for reducing mRNA toxicity, improving efficacy, and future development.

Citation Download Citation

Sijia Yang "mRNA vaccines in cancer immunotherapy: clinical benefits, limitations, and future", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 126116A (24 March 2023); https://doi.org/10.1117/12.2669938

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available